Asia-Pacific Irritable Bowel Syndrome (IBS) Market Analysis 2012-2017 and Forecast 2018-2023

ReportPage
Report ID
33861
Published Date
12-Apr
No of Report Page
96
Report Category
Pharmaceuticals and Healthcare
Editor's Rating
US $6,600.00
US $6,600.00
US $3,300.00

  • Report Details

    Snapshot
    Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS

    More...
  • Table Of Content

    Table of Content
    1 Industry Overview
    1.1 Irritable Bowel Syndrome (IBS) Industry
    1.1.1 Overview
    1.1.2 Development of Irritable Bowel Syndrome (IBS)
    1.2 Market Segment
    1.2.1 By Product Type
    1.2.2 By Application
    1.3 Asia-Pacific Overview
    2 Major Companies List
    2.1 Valeant Pharmaceuticals (Company Profile, Products & Services, Sales Data etc.)
    2.2 A

    More...
  • Inquiry Before Buying
    Inquiry Before Buying -
  • Request Sample
    Request For Sample